• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

19/09/2025 10:19

Aurobindo Pharma - Curateq Biologics Announces Successful Completion Of Phase 3 Clinical Study For Denosumab Biosimilar.

Submission of disclosure of successful of phase 3 clinical study for Denosumab Biosimilar by CuraTeQ Biologics Private Limited, a wholly owned subsidiary of the Company.